Leef Brands (LEEEF) Assets (2024 - 2026)

Leef Brands (LEEEF) posted Assets of $41.9 million for Q1 2026, up 14.96% sequentially from $36.4 million in Q4 2025.

Leef Brands (LEEEF) Assets (2024 - 2026) Analysis & Trends

Leef Brands has reported Assets for 3 years, with the latest figure at $41.9 million in Q1 2026.

Quarterly Assets changed N/A year-over-year to $41.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.9 million (changed N/A YoY) and the FY2025 annual result came in at $36.4 million, down 15.3% from the prior year.
Assets climbed to $41.9 million in Q1 2026 per LEEEF's latest filing, from $36.4 million in the prior quarter.
Over five years, Assets peaked at $43.0 million in Q4 2024 and troughed at $36.4 million in Q4 2025.
A 3-year average of $40.4 million and a median of $41.9 million in 2026 frame the typical range for Assets.
The widest YoY moves for Assets: up 15.3% in 2025, down 15.3% in 2025.
Over 3 years, Assets stood at $43.0 million in 2024, then fell by 15.3% to $36.4 million in 2025, then increased by 14.96% to $41.9 million in 2026.
According to Business Quant data, Assets over the past three periods registered $41.9 million, $36.4 million, and $43.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	43.71 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	39.86 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	15.08 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	98.27 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	7.22 Bn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	35.04 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	5.36 Bn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	13.56 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	6.18 Bn
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn	52.41 Mn

Download Data